Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 14Colonic Neoplasms 11Rectal Neoplasms 10Stomach Neoplasms 8Cholangiocarcinoma 8Neoplasm Metastasis 7Esophageal Neoplasms 3Carcinoma, Hepatocellular 3Neoplasms 2Liver Neoplasms 2Cirrhosis, Familial, with Pulmonary Hypertension 2Adenocarcinoma Of Esophagus 2Pancreatic Neoplasms 1Ovarian Neoplasms 1Genetic Diseases, Inborn 1Gastrointestinal Stromal Tumors 1Gastrointestinal Neoplasms 1Colorectal Adenocarcinoma Metastatic to the Liver 1Carcinoma, Pancreatic Ductal 1Carcinoma, Ovarian Epithelial 1Bile Duct Neoplasms 1Appendiceal Neoplasms 1Adrenocortical Carcinoma 1Adrenal Gland Neoplasms 1Adrenal Cortex Neoplasms 1

Interventions

Oxaliplatin 10Capecitabine 9Cisplatin 8Fluorouracil 5Leucovorin 4Bevacizumab 4tegafur-gimeracil-oteracil 3pemigatinib 3atezolizumab 3Nivolumab 3trebananib 2ponatinib 2pembrolizumab 2avelumab 2apatinib 2alectinib 2XELOX 2Standard of Care 2S 1 (combination) 2Radiotherapy 2Radiosurgery 2Ocoxin 2Irinotecan 2Ipilimumab 2Gemcitabine 2Folfox protocol 2Everolimus 2Erlotinib Hydrochloride 2Acupuncture Therapy 2zanidatamab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Gastrointestinal Neoplasms × Floxuridine × Clear all
NCT00019760 2023-10-31

Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon âš¡